# P-Rex1 limits the agonist-induced internalization of GPCRs independently of its Rac-GEF activity

**Authors:** Martin J. Baker, Elizabeth Hampson, Priota Islam, Ruben Pelaez Moral, Eve A. Maunders, Kirsti Hornigold, Elpida Tsonou, Angeliki Malliri, David C. Hornigold, Roderick E. Hubbard, Andrew J. Massey, Heidi C.E. Welch

PMC · DOI: 10.1016/j.celrep.2025.116403 · Cell Reports · 2025-10-14

## TL;DR

P-Rex1 limits the movement of certain receptors inside cells, independent of its usual signaling role, which could impact processes like immunity and cancer.

## Contribution

P-Rex1 controls GPCR trafficking via an adapter function, independent of its Rac-GEF activity.

## Key findings

- P-Rex1 inhibits agonist-induced internalization of S1PR1, CXCR4, PAR4, and GLP1R.
- P-Rex1 binds Grk2 and blocks phosphorylation required for GPCR internalization.
- P-Rex1 does not affect steady-state GPCR levels or PDGFR/EGFR trafficking.

## Abstract

The guanine-nucleotide exchange factor (GEF) P-Rex1 mediates G protein-coupled receptor (GPCR) signaling by activating the small GTPase Rac. We show here that P-Rex1 also controls GPCR trafficking. P-Rex1 inhibits the agonist-stimulated internalization of the GPCR S1PR1 independently of its Rac-GEF activity, through its PDZ, DEP, and inositol polyphosphate 4-phosphatase domains. P-Rex1 also limits the agonist-induced trafficking of CXCR4, PAR4, and GLP1R but does not control steady-state GPCR levels, nor the agonist-induced internalization of the receptor tyrosine kinases PDGFR and EGFR. P-Rex1 blocks the phosphorylation required for GPCR internalization. P-Rex1 binds G protein-coupled receptor kinase 2 (Grk2), both in vitro and in cells, but does not appear to regulate Grk2 activity. We propose that P-Rex1 limits the agonist-induced internalization of GPCRs through its interaction with Grk2 to maintain high levels of active GPCRs at the plasma membrane. Therefore, P-Rex1 plays a dual role in promoting GPCR responses by controlling GPCR trafficking through an adapter function as well as by mediating GPCR signaling through its Rac-GEF activity.

•P-Rex1 controls GPCR trafficking, independently of its Rac-GEF activity•P-Rex1 limits the agonist-induced internalization of S1PR1, CXCR4, PAR4, and GLP1R•P-Rex1 does not control steady-state GPCR levels, nor PDGFR or EGFR trafficking•P-Rex1 binds Grk2 and inhibits the phosphorylation required for GPCR internalization

P-Rex1 controls GPCR trafficking, independently of its Rac-GEF activity

P-Rex1 limits the agonist-induced internalization of S1PR1, CXCR4, PAR4, and GLP1R

P-Rex1 does not control steady-state GPCR levels, nor PDGFR or EGFR trafficking

P-Rex1 binds Grk2 and inhibits the phosphorylation required for GPCR internalization

P-Rex1 activates Rac downstream of GPCRs to regulate processes ranging from innate immunity to neuronal plasticity, its deregulation contributing to cancer. Here, Baker et al. show that P-Rex1 also controls GPCR trafficking, limiting agonist-induced GPCR internalization through an adapter function. Thus, P-Rex1 promotes GPCR responses in a dual manner.

## Linked entities

- **Genes:** PREX1 (phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1) [NCBI Gene 57580], S1PR1 (sphingosine-1-phosphate receptor 1) [NCBI Gene 1901], CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852], PAWR (pro-apoptotic WT1 regulator) [NCBI Gene 5074], GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740], GRK2 (G protein-coupled receptor kinase 2) [NCBI Gene 156], PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159], EGFR (epidermal growth factor receptor) [NCBI Gene 1956], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207]
- **Proteins:** PREX1 (phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1), FZD4 (frizzled class receptor 4), GRK2 (G protein-coupled receptor kinase 2), AKT1 (AKT serine/threonine kinase 1)

## Full-text entities

- **Genes:** GRK2 (G protein-coupled receptor kinase 2) [NCBI Gene 156] {aka ADRBK1, BARK1, BETA-ARK1}, PWAR4 (Prader Willi/Angelman region RNA 4) [NCBI Gene 347745] {aka PAR-4, PAR4}, CXCR6 (C-X-C motif chemokine receptor 6) [NCBI Gene 10663] {aka BONZO, CD186, CDw186, STRL33, TYMSTR}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, PREX1 (phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1) [NCBI Gene 57580] {aka P-REX1}, PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159] {aka CD140B, IBGC4, IMF1, JTK12, KOGS, OPDKD}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, S1PR1 (sphingosine-1-phosphate receptor 1) [NCBI Gene 1901] {aka CD363, CHEDG1, D1S3362, ECGF1, EDG-1, EDG1}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12569377/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12569377/full.md

## References

100 references — full list in the complete paper: https://tomesphere.com/paper/PMC12569377/full.md

---
Source: https://tomesphere.com/paper/PMC12569377